Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Dalvabancin – Second-Generation Glycopeptide for Serious Gram-Positive Infections

Vicuron Pharmaceuticals’ development pipeline.



  • Treatment of infections due to MRSA
  • Evolution of new antibiotic classes
  • Antibiotic resistance
  • Classes of antibiotics
  • Skin and soft tissue infections
  • Vicuron Pharmaceuticals

Go Top